Disease Outcome in Inflammatory Bowel Disease: Mortality, Morbidity and Therapeutic Management of a 796-Person Inception Cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

References

• Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn’s disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818–25.
   Google Scholar
• Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 1993;105:1716–23.
   PubMed Web of Science ®Google Scholar
• Mendelsohn RR, Korelitz BI, Gleim GW. Death from Crohn’s disease: lessons from a personal experience. J Clin Gastroenterol 1995;20:22–6.
   Google Scholar
• Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol 1997;11:53–64.
   PubMed Web of Science ®Google Scholar
• Softley A, Clamp SE, Watkinson G, Bouchier IAD, Myren J, de Dombal FT. The natural history of inflammatory bowel disease: has there been a change in the last 20 years? Scand J Gastroenterol 1988;23 Suppl 144:20–3.
   Google Scholar
• Binder V. Prognosis and quality of life in patients with ulcerative colitis and Crohn’s disease. Int Disabil Stud 1988;10:172–4.
   PubMedGoogle Scholar
• Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wochenschr 1988; 118:738–42.
   PubMedGoogle Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350–8.
   PubMed Web of Science ®Google Scholar
• Samuelsson SM, Ekbom A, Zack M, Helmick CG, Adami HO. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991;32: 1526–30.
   Google Scholar
• Hodgson HJ. The natural history of treated ulcerative colitis [editorial; comment]. Gastroenterology 1994;107:300–2.
   PubMedGoogle Scholar
• Probert CSJ, Jayanthi V, Wicks ACB, Mayberry JF. Mortality from Crohn’s disease in Leicestershire, 1972–1989: an epidemiological community based study. Gut 1992;33:1226–8.
   PubMed Web of Science ®Google Scholar
• Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D’Albasio G, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study. Gut 1998;42:175–9.
   Google Scholar
• Shivananda S, Lennard-Jones JE, Logan RF, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE, Shivananda S, EC-IBD Study Group. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997;9: 353–9.
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl 170:2–6.
   Web of Science ®Google Scholar
• Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Am J Gastroenterol 1993;88: 1188–79.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26: 1247–56.
   Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27: 609–14.
   Google Scholar
• Myren J, Bouchier IA, Watkinson G, Softley A, Clamp SE, de Dombal FT. The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976–1982. A further report on 2,657 cases. Scand J Gastroenterol 1984;95 Suppl:1–27.
   Google Scholar
• Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997;40:328–32.
   PubMed Web of Science ®Google Scholar
• Dekker-saeys BJ, Meeuwissen SGM, van den Berg-Loonen EM, De Haas WHD, Agenant D, Tytgat GN. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis 1978;37:33–5.
   Google Scholar
• Greenstein A, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55: 401–12.
   Google Scholar
• Rankin GB, Watts HD, Melnyk CS, Kelley MLJ. National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77: 914–20.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 1996;110:424–31.
   Google Scholar
• Russel MG, Nieman FH, Bergers JM, Stockbrugger RW. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J Gastroenterol Hepatol 1996;8:1075–81.
   PubMed Web of Science ®Google Scholar
• Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989; 18:105–7.
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn’s disease. Gastroenterology 1990;98:1123–8.
   PubMed Web of Science ®Google Scholar
• Timmer A, Sutherland L, Martin F. The Canadian mesalamine for remission of Crohn’s disease study group. Contraceptive use and smoking are risk factors for relapse in Crohn’s disease. Gastroenterology 1998;114:1143–50.
   Google Scholar
• Brostrom O. Prognosis in ulcerative colitis. Med Clin North Am 1990;74:201–18.
   PubMed Web of Science ®Google Scholar
• Davoli M, Prantera C, Berto E, Scribano ML, D’Ippoliti D. Mortality among patients with ulcerative colitis: Rome 1970–1989. Eur J Epidemiol 1997;13: 189–94.
   Google Scholar
• Ekbom A, Hemlick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population based study. Gastroenterology 1992; 103:954–60.
   Google Scholar